• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

Publication
Article
Supplements and Featured PublicationsValue-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.